Literature DB >> 26866355

Basaloid Squamous Cell Carcinoma of the Anus Revisited.

Rondell P Graham1, Christina A Arnold, Bita V Naini, Dora M Lam-Himlin.   

Abstract

Basaloid squamous cell carcinoma (SCC) of the anus, previously called cloacogenic carcinoma, is a subtype of SCC. There are very few data on the morphologic variation within basaloid SCC of the anus, which may contribute to misdiagnosis. We retrospectively evaluated cases originally diagnosed as basaloid SCC for histologic characterization. We retrieved and reviewed cases of basaloid SCC from 1994 to 2013. Ten (27%) cases were reclassified after review, including basal cell carcinoma (n=6), melanoma (n=2), and neuroendocrine carcinoma (n=2). The final group of basaloid SCC (n=27) showed a female predominance (median age=60 y; range, 42 to 92 y). Morphologically, basaloid SCC could be categorized into 4 groups: transitional carcinoma like (n=10), basaloid with peripheral palisade (n=13), adenoid cystic carcinoma like (n=3), and mucinous microcystic (n=1). In 19 cases the histologic patterns were pure and were mixed in the remainder. CK5/6, p16, and high-risk HPV were positive in all cases (n=27). SOX2 was positive in 18/22 cases. Clinical follow-up was available on 60% of cases; 9 patients (53%) developed local recurrence or metastasis, and 5 (29%) died of disease. Basaloid SCC of the anus is characterized by 4 major histologic patterns and is consistently HPV driven.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26866355     DOI: 10.1097/PAS.0000000000000594

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features.

Authors:  Mark Zupancic; Stefan Holzhauser; Liquin Cheng; Torbjörn Ramqvist; Juan Du; Signe Friesland; Anders Näsman; Tina Dalianis
Journal:  Viruses       Date:  2022-05-13       Impact factor: 5.818

2.  Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.

Authors:  Xiaoqin Zhu; Sarah Jamshed; Jian Zou; Azniv Azar; Xiuling Meng; Venu Bathini; Karen Dresser; Cara Strock; Bhargavi Yalamarti; Michelle Yang; Keith Tomaszewicz; George Tjionas; Mark C Mochel; Lloyd Hutchinson; Jacob R Bledsoe
Journal:  Mod Pathol       Date:  2021-01-22       Impact factor: 8.209

3.  A rare case of recurrent epidermoid anal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-case report.

Authors:  Vera Pravong; Alexandre Brind'Amour; Lucas Sidéris; Pierre Dubé; Jean-François Tremblay
Journal:  World J Surg Oncol       Date:  2020-07-04       Impact factor: 2.754

Review 4.  Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review.

Authors:  Linxiu Liu; Xuemin Xue; Liyan Xue
Journal:  Diagn Pathol       Date:  2019-09-06       Impact factor: 2.644

Review 5.  Unusual Faces of Bladder Cancer.

Authors:  Claudia Manini; José I López
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

6.  Survival rate variation with different histological subtypes of poor prognostic male anal squamous cell carcinoma: a population-based study.

Authors:  Zihao Wan; Zhihao Huang; Vikash Vikash; Kelash Rai; Sindhu Vikash; Liaobin Chen; Jingfeng Li
Journal:  Oncotarget       Date:  2017-09-16

7.  CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma.

Authors:  Erik A Williams; Meagan Montesion; Radwa Sharaf; James Corines; Parth J Patel; Brendan J Gillespie; Dean C Pavlick; Ethan S Sokol; Brian M Alexander; Kevin Jon Williams; Julia A Elvin; Jeffrey S Ross; Shakti H Ramkissoon; Amanda C Hemmerich; Julie Y Tse; Mark C Mochel
Journal:  Mod Pathol       Date:  2020-05-27       Impact factor: 7.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.